Donguian, Julan S.
HRN: 21-88-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/09/2022
09/16/2022
IV
1.5 G
Q8
Multiple Abrasions
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes